NEW APPROACHES TO THE THERAPY OF MILD HYPERTENSION

被引：33
作者：
KAPLAN, NM
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1983年 / 51卷 / 04期
关键词：
D O I：
10.1016/S0002-9149(83)80198-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：621 / 627
页数：7
相关论文
共 42 条
[1]   MANAGEMENT OF THE HYPERTENSIVE PATIENT - A CONTINUING DILEMMA [J].
ALDERMAN, MH ;
MADHAVAN, S .
HYPERTENSION, 1981, 3 (02) :192-197
[2]  
AMERY A, 1978, LANCET, V1, P681
[3]   IMPROVEMENT OF GLUCOSE-TOLERANCE AND LOWERING OF GLYCOHEMOGLOBIN AND SERUM-LIPID CONCENTRATIONS AFTER DISCONTINUATION OF ANTIHYPERTENSIVE DRUG-THERAPY [J].
AMES, RP ;
HILL, P .
CIRCULATION, 1982, 65 (05) :899-904
[4]   EFFECTS OF TREATMENT ON MORBIDITY IN HYPERTENSION - RESULTS IN PATIENTS WITH DIASTOLIC BLOOD PRESSURES AVERAGING 115 THROUGH 129 MM HG [J].
不详 .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (11) :1028-&
[5]  
[Anonymous], 1981, LANCET, V2, P539
[6]  
[Anonymous], 1980, LANCET, V1, P1261
[7]  
BERGLUND G, 1981, LANCET, V1, P744
[8]   LABETALOL - REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN HYPERTENSION [J].
BROGDEN, RN ;
HEEL, RC ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1978, 15 (04) :251-270
[9]   ANTIHYPERTENSIVE BETA-BLOCKING ACTION AS RELATED TO RENIN AND AGE - PHARMACOLOGIC TOOL TO IDENTIFY PATHOGENETIC MECHANISMS IN ESSENTIAL HYPERTENSION [J].
BUHLER, FR ;
BURKART, F ;
LUTOLD, BE ;
KUNG, M ;
MARBET, G ;
PFISTERER, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1975, 36 (05) :653-669
[10]   MULTIPLE RISK FACTOR INTERVENTION TRIAL (MRFIT) .6. INTERVENTION ON BLOOD-PRESSURE [J].
COHEN, JD ;
GRIMM, RH ;
SMITH, WM .
PREVENTIVE MEDICINE, 1981, 10 (04) :501-518
12345